Yoshiharu Hayashi, Ph.D. has joined the board of directors of TRL from April, 2018. Dr. Hayashi has more than 16 years of experience as a pharmacologist since 1987 when he joined Yoshitomi Pharmaceutical Industries, one of the preceding companies of Mitsubishi Tanabe Pharma Corporation (MTPC). Dr.Hayashi first led an anti-diabetic drug project in the research laboratory and then, served as the Project Leader to manage clinical development of the candidate drug. After the drug was launched in the market, Dr.Hayashi returned to the research laboratory and served as the head of the Research Unit/ Nephrological & Endocrinological Science from 2015 to 2017. Dr. Hayashi currently serves as Executive Officer and General Manager of the Sohyaku (Innovative Research) Project Planning & Management Department of MTPC. Dr. Hayashi received his Ph.D. from Tohoku University in 2000.